While the potential anti-hypertensive effect of activating PPARδ post additional beneficial effect when treating heart failure patients with hypertension, other systemic effects of PPARδ remain major confounding factors preventing the potential application. The gene discussed is PPARD; the disease is hypertensive disorder.